With their depth of knowledge and experience, CVC thought leaders are able to both understand and address the multiple challenges associated with the regulatory, financial and operational aspects of clinical research. Some key elements of their research-related …
With over 20 years of experience in clinical trial operations for Phase II/III/IV, registry, and investigator initiated studies, the CVC clinical trials team has the expertise and knowledge to deliver a high quality and well …
Biostatistics at the CVC is a collective of applied biostatisticians with diverse training, experience, and practice. We collaborate with local, national, and international investigative teams by advising and applying statistical reasoning and methods to the …
The CVC Population Health and Economic Outcomes team is actively involved in examining population-level issues related to access, delivery, treatment, and outcomes of heart disease in Alberta and Canada. Health care administrative databases serve as …
The Artificial Intelligence and Machine Learning (AI/ML) team at the CVC is working with large-scale population level datasets to uncover novel and actionable insights that can potentially assist clinical decision making. To this end, our …
ECG Core Lab The CVC ECG Core Laboratory continues to evaluate patient data into clinically meaningful findings that have real world relevance. Using quantitative data, the electrocardiogram (ECG) – a venerable but powerful biomarker – can …
The business operations group is fundamental to the organizational and financial underpinnings of the CVC. Our knowledgeable team provides expert service and oversees the negotiation and administration of agreements and contracts, budget development, financial operations …
The section has information on the trials that the CVC is currently working on, some of which are recruiting and others that are in the follow-up or closeout phase. If you are interested in learning …
Below you will find information about the population based research projects that are currently underway at the CVC. Through the interrogation of registries and population health data, the CVC is steadfastly dedicated to our organization’s …
As a learning organization committed to enhancing the health of current and future generations through research, the CVC relentlessly pursues the generation, translation, and dissemination of new knowledge addressing unmet clinical needs. This section highlights …
The Canadian Cardiac Chronicle is a quarterly newsletter that includes information about the CVC's current trials and upcoming projects, as well as a list of recent publications from our faculty. The Chronicle is distributed to …
As an Academic Research Organization, the Canadian VIGOUR Centre is held to a high standard of both fiscal and academic responsibility. Browse through our current and past annual reports below to find out more. The digital …
Based on recommendations from the International Committee of Medical Journal Editors (ICMJE) published in the New England Journal of Medicine (NEJM) on June 8, 2017, the CVC recognizes the value and importance of making data …
Beyond 2000 (B2K) is a symposium held each year in conjunction with the Canadian Cardiovascular Congress. The symposium is comprised of two sequential sessions – the first on acute coronary syndromes (ACS), and the second …
The CVC Scholar Program is a unique training initiative designed to advance research and further understanding of cardiovascular disease through the educational and financial support of the Canadian VIGOUR Centre (CVC). Trainees participating in this …
The CVC Clinical Trials Colloquium first began in 2014 when Dr. Paul Armstrong (CVC Founding Director) and Tracy Temple (Associate Director, Clinical Trials), brought together 13 Canadian investigative sites to help: Identify major impediments to timely …
ACC/AHA Joint Guidelines These guidelines are a listing of the standards and updates related to diagnosis, management, and care of patients with cardiovascular disease from the American College of Cardiology and the American Heart Association. CCS …
In this section you will find links to important and useful documents produced by Health Canada which relate to the regulatory functions of the Health Products and Food Branch Inspectorate. This group is responsible for the inspections …
Good Clinical Practice (GCP) is an international ethical and scientific quality standard for designing, conducting, recording and reporting trials that involve the participation of human subjects. The ICH GCP Guideline was developed with consideration of …
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of the Oral Soluble Guanylate Cyclase Stimulator: The VICTORIA Trial.Armstrong PW, Roessig L, Patel MJ, Anstrom KJ, Butler J, Voors AA, Lam CSP, Ponikowski …
Late-Breaking Clinical Trial Presentation The VICTORIA trial was presented as a Late-Breaking Clinical Trial on March 28, 2020 at the virtual American College of Cardiology’s 69th Annual Scientific Session Together With World Congress of Cardiology (ACC.20/WCC). Other …
Below is a summary of completed, in progress, and planned secondary analyses for the VICTORIA study. AnalysesStatus (Completed, In Progress, Planned)Related LinksContextual with other trialsCompletedCirculation publicationImpact of natriuretic peptides on result and their evolutionCompletedJACC FF publicationHFA …
Press Releases Patient Enrollment (2016) University of Alberta Press Release Study Results (March 2020) University of Alberta Press ReleaseAmerican College of Cardiology Press ReleaseBayer Press ReleaseMerck Press Release U.S. FDA Approval (January 2021) Merck Press ReleaseBayer Press ReleaseUniversity of Alberta Press …
VICTORIA Data Sharing Charter (PDF) VICTORIA Research Proposal Form Per the VICTORIA Data Sharing Charter, this form is provided for qualified researchers to submit a data request for patient-level data to the VICTORIA Publications Committee for review. Data …
VICTORIA Clinical Study Results Lay Summary (PDF)
Download the VICTORIA FAQs Document (PDF)
The Canadian VIGOUR Centre (CVC) was established in 1997 as the Canadian arm of the international VIGOUR (Virtual Coordinating Centre for Global Collaborative Cardiovascular Research) Group. Since its inception, our centre has undertaken over 60 …
Vision Generate, translate and disseminate knowledge on novel diagnostic and therapeutic strategies in cardiovascular medicine acquired through collaborative research to enhance the health of the citizens of Alberta, Canada, and the world. Mission Aligned with the University of …
The following facts and figures highlight some of the CVC’s key accomplishments to date.
The CVC Faculty are internationally recognized as Thought Leaders in their respective areas of interest, and they collectively represent a diverse field of clinical research. Our faculty are passionately dedicated to advancing the frontiers of …
Relationships with industry disclosure statements for the Canadian VIGOUR Centre’s faculty members are provided below. These statements are considered proprietary and are not to be distributed, downloaded for repeat use, or reproduced in any way …
The CVC has forged strong partnerships with a number of institutions and centres around the world in the pursuit of novel research directions and the advancement of cardiovascular research. The CVC takes great pride in …
The CVC embraces an enthusiastic commitment to fostering a research environment conducive to disciplined academic inquiry, novel approaches to clinically relevant questions, and robust methodologies. We are pleased to offer research opportunities to undergraduates, medical …
We are pleased to share the 2021 CVC annual report. This year’s theme, Global Vision ⟷ Local Action, highlights a variety of the CVC’s activities that have started at a global or national scale and have …
Home > VICTORIA > FAQs
